---
authors:
- North, Michael D
- DeCastro, Alexei O
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/39700355/
file_path: 2024/12/sglt-2-inhibitors-for-individuals-with-diabetes-and-chronic.md
issue: '6'
keywords:
- Diabetes
last_updated: '2025-07-30'
original_format: PubMed
pages: online
patient_population: Adults
peer_reviewed: true
pmid: '39700355'
processed_date: '2025-07-30'
publication_date: '2024-12-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: SGLT-2 Inhibitors for Individuals With Diabetes and Chronic Kidney Disease.
topics:
- Diabetes Mellitus
- Endocrinology
- Family Medicine
- Metabolic Disorders
volume: '110'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '39700355'
  title: SGLT-2 Inhibitors for Individuals With Diabetes and Chronic Kidney Disease.
  authors:
  - last_name: North
    fore_name: Michael D
    initials: MD
    affiliation: Medical University of South Carolina, Charleston.
  - last_name: DeCastro
    fore_name: Alexei O
    initials: AO
    affiliation: Medical University of South Carolina, Charleston.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '110'
    issue: '6'
  publication_info:
    year: '2024'
    month: '12'
    full_date: '2024-12-01'
  article_ids: {}
  publication_types: *id001
related_articles:
- pmid: '39700355'
  title: SGLT-2 Inhibitors for Individuals With Diabetes and Chronic Kidney Disease.
  authors:
  - name: North MD
    authtype: Author
    clusterid: ''
  - name: DeCastro AO
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2024 Dec
- pmid: '39574422'
  title: 'Sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney
    disease with or without type 2 diabetes: systematic review and meta-analysis.'
  authors:
  - name: Zou X
    authtype: Author
    clusterid: ''
  - name: Shi Q
    authtype: Author
    clusterid: ''
  - name: Olav Vandvik P
    authtype: Author
    clusterid: ''
  - name: Mao Y
    authtype: Author
    clusterid: ''
  - name: Agarwal A
    authtype: Author
    clusterid: ''
  - name: Ponte B
    authtype: Author
    clusterid: ''
  - name: Zeng X
    authtype: Author
    clusterid: ''
  - name: Guyatt G
    authtype: Author
    clusterid: ''
  - name: Yang Q
    authtype: Author
    clusterid: ''
  - name: Luo X
    authtype: Author
    clusterid: ''
  - name: Xu C
    authtype: Author
    clusterid: ''
  - name: Fu P
    authtype: Author
    clusterid: ''
  - name: Tian H
    authtype: Author
    clusterid: ''
  - name: Agoritsas T
    authtype: Author
    clusterid: ''
  - name: Li S
    authtype: Author
    clusterid: ''
  source: BMJ Med
  pubdate: '2024'
- pmid: '39353639'
  title: 'Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic
    kidney disease: a clinical practice guideline.'
  authors:
  - name: Agarwal A
    authtype: Author
    clusterid: ''
  - name: Zeng X
    authtype: Author
    clusterid: ''
  - name: Li S
    authtype: Author
    clusterid: ''
  - name: Rayner D
    authtype: Author
    clusterid: ''
  - name: Foroutan F
    authtype: Author
    clusterid: ''
  - name: Aertgeerts B
    authtype: Author
    clusterid: ''
  - name: Coyac F
    authtype: Author
    clusterid: ''
  - name: Farhoumand PD
    authtype: Author
    clusterid: ''
  - name: Demaine A
    authtype: Author
    clusterid: ''
  - name: Heen AF
    authtype: Author
    clusterid: ''
  - name: Jha V
    authtype: Author
    clusterid: ''
  - name: Machuve E
    authtype: Author
    clusterid: ''
  - name: Nagler E
    authtype: Author
    clusterid: ''
  - name: Tunnicliffe DJ
    authtype: Author
    clusterid: ''
  - name: Guyatt GH
    authtype: Author
    clusterid: ''
  - name: Vandvik PO
    authtype: Author
    clusterid: ''
  - name: Ponte B
    authtype: Author
    clusterid: ''
  - name: Agoritsas T
    authtype: Author
    clusterid: ''
  source: BMJ
  pubdate: 2024 Oct 1
- pmid: '30767677'
  title: The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure
    and chronic kidney disease in type 2 diabetes.
  authors:
  - name: Woo V
    authtype: Author
    clusterid: ''
  - name: Connelly K
    authtype: Author
    clusterid: ''
  - name: Lin P
    authtype: Author
    clusterid: ''
  - name: McFarlane P
    authtype: Author
    clusterid: ''
  source: Curr Med Res Opin
  pubdate: 2019 Jul
- pmid: '37809091'
  title: Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney
    disease.
  authors:
  - name: Dai ZC
    authtype: Author
    clusterid: ''
  - name: Chen JX
    authtype: Author
    clusterid: ''
  - name: Zou R
    authtype: Author
    clusterid: ''
  - name: Liang XB
    authtype: Author
    clusterid: ''
  - name: Tang JX
    authtype: Author
    clusterid: ''
  - name: Yao CW
    authtype: Author
    clusterid: ''
  source: Front Immunol
  pubdate: '2023'
---

# SGLT-2 Inhibitors for Individuals With Diabetes and Chronic Kidney Disease.

**Authors:** North, Michael D, DeCastro, Alexei O

**Published in:** American family physician | Vol. 110, No. 6 | 2024-12-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/39700355/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Diabetes Mellitus, Endocrinology, Family Medicine, Metabolic Disorders

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/39700355/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
